STOCK TITAN

[Form 4] Aflac Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Joseph L. Moskowitz, identified as a Director of Aflac Inc., reported the sale of 1,000 shares of Aflac common stock on 08/08/2025 at a price of $102.57 per share. After the reported transaction the filing shows he beneficially owned 25,105 shares. The Form 4 indicates it was filed by one reporting person and bears a signature date of 08/12/2025.

The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2024. No derivative transactions are reported in the document, and the form includes the reporting person's address and role. The disclosure is limited to the transactions described and the plan referenced.

Joseph L. Moskowitz, identificato come membro del consiglio di amministrazione di Aflac Inc., ha segnalato la vendita di 1,000 azioni ordinarie di Aflac in data 08/08/2025 al prezzo di $102.57 per azione. Dopo la transazione comunicata, la dichiarazione riporta che deteneva beneficiamente 25,105 azioni. Il Form 4 indica che è stato presentato da un'unica persona segnalante e reca la data di firma 08/12/2025.

La comunicazione precisa che le vendite sono state eseguite ai sensi di un piano di negoziazione Rule 10b5-1 adottato dalla persona segnalante il 4 dicembre 2024. Nel documento non sono riportate transazioni su strumenti derivati e il modulo include l'indirizzo e la qualifica della persona segnalante. La divulgazione è limitata alle operazioni descritte e al piano citato.

Joseph L. Moskowitz, identificado como miembro del consejo de administración de Aflac Inc., informó la venta de 1,000 acciones ordinarias de Aflac el 08/08/2025 a $102.57 por acción. Tras la transacción informada, la presentación indica que poseía beneficiariamente 25,105 acciones. El Formulario 4 señala que fue presentado por una sola persona informante y lleva la fecha de firma 08/12/2025.

La presentación declara que las ventas se realizaron en virtud de un plan de negociación Rule 10b5-1 adoptado por la persona informante el 4 de diciembre de 2024. En el documento no se informan transacciones con derivados y el formulario incluye la dirección y el cargo de la persona informante. La divulgación se limita a las transacciones descritas y al plan mencionado.

Joseph L. Moskowitz는 Aflac Inc.의 이사로 확인되며, 08/08/2025에 Aflac 보통주 1,000주를 주당 $102.57에 매도했다고 보고했습니다. 보고된 거래 이후 제출서류에는 그가 실질적으로 보유한 주식이 25,105주라고 기재되어 있습니다. Form 4에는 한 명의 보고자가 제출한 것으로 되어 있고 서명일은 08/12/2025입니다.

서류에는 해당 매도는 보고자가 2024년 12월 4일에 채택한 Rule 10b5-1 거래계획에 따라 실행되었다고 명시되어 있습니다. 문서에는 파생상품 거래가 보고되어 있지 않으며, 양식에는 보고자의 주소와 직책이 포함되어 있습니다. 공시는 기재된 거래와 언급된 계획에 한정됩니다.

Joseph L. Moskowitz, identifié comme membre du conseil d'administration d'Aflac Inc., a déclaré la vente de 1,000 actions ordinaires d'Aflac le 08/08/2025 au prix de $102.57 par action. Après la transaction déclarée, le dossier indique qu'il détenait effectivement 25,105 actions. Le Formulaire 4 précise qu'il a été déposé par une seule personne déclarante et porte la date de signature 08/12/2025.

Le document indique que les ventes ont été effectuées en vertu d'un plan de négociation Rule 10b5-1 adopté par la personne déclarante le 4 décembre 2024. Aucune transaction sur produits dérivés n'est signalée dans le document, et le formulaire inclut l'adresse et la fonction de la personne déclarante. La divulgation se limite aux opérations décrites et au plan mentionné.

Joseph L. Moskowitz, angegeben als Mitglied des Verwaltungsrats von Aflac Inc., meldete den Verkauf von 1,000 Aflac-Stammaktien am 08/08/2025 zu einem Preis von $102.57 pro Aktie. Nach der gemeldeten Transaktion weist die Einreichung aus, dass er wirtschaftlich 25,105 Aktien besaß. Das Form 4 gibt an, dass es von einer meldenden Person eingereicht wurde und trägt das Unterschriftsdatum 08/12/2025.

Die Einreichung besagt, dass die Verkäufe aufgrund eines am 4. Dezember 2024 vom Meldenden angenommenen Rule 10b5-1-Handelsplans durchgeführt wurden. Im Dokument sind keine Derivatgeschäfte angegeben, und das Formular enthält die Adresse und die Funktion der meldenden Person. Die Offenlegung beschränkt sich auf die beschriebenen Transaktionen und den genannten Plan.

Positive
  • Sale executed under a Rule 10b5-1 trading plan (adopted December 4, 2024), indicating the trades were pre-arranged under an approved plan.
  • Form 4 filed and signed (signature dated 08/12/2025) documenting the transaction and meeting disclosure requirements.
Negative
  • None.

Insights

TL;DR: Director sold 1,000 AFL shares under a pre-arranged 10b5-1 plan; the transaction is documented and appears routine.

The Form 4 reports a single non-derivative sale of 1,000 Aflac shares on 08/08/2025 at $102.57 per share, leaving 25,105 shares beneficially owned. The sale was executed under a Rule 10b5-1 plan adopted on December 4, 2024, which indicates the trades were pre-authorized rather than opportunistic. No options, warrants, or other derivative positions are listed, limiting complexity. Based solely on the filing, the disclosure is routine and provides required transparency to investors.

TL;DR: Filing shows adherence to insider-trading protocols with a disclosed 10b5-1 plan and timely Form 4 reporting.

The report identifies Joseph L. Moskowitz as a director and documents the sale as effected pursuant to a Rule 10b5-1 plan dated December 4, 2024. The Form 4 was signed on 08/12/2025, following the 08/08/2025 transaction. These elements reflect compliance with disclosure requirements and the use of an approved trading plan. The filing contains no indications of amendments, derivative transactions, or other governance concerns within the provided text.

Joseph L. Moskowitz, identificato come membro del consiglio di amministrazione di Aflac Inc., ha segnalato la vendita di 1,000 azioni ordinarie di Aflac in data 08/08/2025 al prezzo di $102.57 per azione. Dopo la transazione comunicata, la dichiarazione riporta che deteneva beneficiamente 25,105 azioni. Il Form 4 indica che è stato presentato da un'unica persona segnalante e reca la data di firma 08/12/2025.

La comunicazione precisa che le vendite sono state eseguite ai sensi di un piano di negoziazione Rule 10b5-1 adottato dalla persona segnalante il 4 dicembre 2024. Nel documento non sono riportate transazioni su strumenti derivati e il modulo include l'indirizzo e la qualifica della persona segnalante. La divulgazione è limitata alle operazioni descritte e al piano citato.

Joseph L. Moskowitz, identificado como miembro del consejo de administración de Aflac Inc., informó la venta de 1,000 acciones ordinarias de Aflac el 08/08/2025 a $102.57 por acción. Tras la transacción informada, la presentación indica que poseía beneficiariamente 25,105 acciones. El Formulario 4 señala que fue presentado por una sola persona informante y lleva la fecha de firma 08/12/2025.

La presentación declara que las ventas se realizaron en virtud de un plan de negociación Rule 10b5-1 adoptado por la persona informante el 4 de diciembre de 2024. En el documento no se informan transacciones con derivados y el formulario incluye la dirección y el cargo de la persona informante. La divulgación se limita a las transacciones descritas y al plan mencionado.

Joseph L. Moskowitz는 Aflac Inc.의 이사로 확인되며, 08/08/2025에 Aflac 보통주 1,000주를 주당 $102.57에 매도했다고 보고했습니다. 보고된 거래 이후 제출서류에는 그가 실질적으로 보유한 주식이 25,105주라고 기재되어 있습니다. Form 4에는 한 명의 보고자가 제출한 것으로 되어 있고 서명일은 08/12/2025입니다.

서류에는 해당 매도는 보고자가 2024년 12월 4일에 채택한 Rule 10b5-1 거래계획에 따라 실행되었다고 명시되어 있습니다. 문서에는 파생상품 거래가 보고되어 있지 않으며, 양식에는 보고자의 주소와 직책이 포함되어 있습니다. 공시는 기재된 거래와 언급된 계획에 한정됩니다.

Joseph L. Moskowitz, identifié comme membre du conseil d'administration d'Aflac Inc., a déclaré la vente de 1,000 actions ordinaires d'Aflac le 08/08/2025 au prix de $102.57 par action. Après la transaction déclarée, le dossier indique qu'il détenait effectivement 25,105 actions. Le Formulaire 4 précise qu'il a été déposé par une seule personne déclarante et porte la date de signature 08/12/2025.

Le document indique que les ventes ont été effectuées en vertu d'un plan de négociation Rule 10b5-1 adopté par la personne déclarante le 4 décembre 2024. Aucune transaction sur produits dérivés n'est signalée dans le document, et le formulaire inclut l'adresse et la fonction de la personne déclarante. La divulgation se limite aux opérations décrites et au plan mentionné.

Joseph L. Moskowitz, angegeben als Mitglied des Verwaltungsrats von Aflac Inc., meldete den Verkauf von 1,000 Aflac-Stammaktien am 08/08/2025 zu einem Preis von $102.57 pro Aktie. Nach der gemeldeten Transaktion weist die Einreichung aus, dass er wirtschaftlich 25,105 Aktien besaß. Das Form 4 gibt an, dass es von einer meldenden Person eingereicht wurde und trägt das Unterschriftsdatum 08/12/2025.

Die Einreichung besagt, dass die Verkäufe aufgrund eines am 4. Dezember 2024 vom Meldenden angenommenen Rule 10b5-1-Handelsplans durchgeführt wurden. Im Dokument sind keine Derivatgeschäfte angegeben, und das Formular enthält die Adresse und die Funktion der meldenden Person. Die Offenlegung beschränkt sich auf die beschriebenen Transaktionen und den genannten Plan.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MOSKOWITZ JOSEPH L

(Last) (First) (Middle)
C/O AFLAC INCORPORATED
1932 WYNNTON ROAD

(Street)
COLUMBUS GA 31999

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AFLAC INC [ AFL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 S 1,000(1) D $102.57 25,105 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated as of December 4, 2024.
Remarks:
By: Brooke R. Phillips For: Joseph L. Moskowitz 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Joseph L. Moskowitz report on the Form 4 for AFL?

He reported a sale of 1,000 Aflac common shares on 08/08/2025 at $102.57 per share.

Was the sale by the Aflac director part of a trading plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2024.

How many Aflac shares did Moskowitz own after the reported transaction?

The Form 4 shows he beneficially owned 25,105 shares following the transaction.

When was the Form 4 signed and filed?

The Form 4 bears a signature date of 08/12/2025 and reports the transaction dated 08/08/2025.

Did the Form 4 disclose any derivative transactions for AFL?

No. Table II for derivative securities contains no reported transactions in the provided filing.
Aflac Inc

NYSE:AFL

AFL Rankings

AFL Latest News

AFL Latest SEC Filings

AFL Stock Data

55.37B
478.15M
10.43%
59.86%
1.51%
Insurance - Life
Accident & Health Insurance
Link
United States
COLUMBUS